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commensal strains of E. coli.
These findings suggest that EHEC
may have evolved mechanisms to
avoid expending energy to transport
and utilize a nutrient that is actively
being used by other microbes, possibly
giving EHEC a competitive advantage
over the microbiota. The fusKR genes,
while present in the EHEC O157:H7
serotype, are notably absent in all other
published genomes of E. coli. It
remains to be seen whether repression
of fucose utilization by the FusKR
response regulator confers a growth
advantage upon EHEC because it can
utilize alternative unique carbon
sources while commensal strains of
E. coli cannot, but it would be telling if
transfer of the cognate FusKR pair to
commensal strains of E. coli conferred
a growth disadvantage to them in the
host. This would raise the mirror
question: if EHEC uses the FusKR
two-component system to abstain
from a carbon source that other
microbiota members use while in
the gastrointestinal tract, has EHEC
gained specific mechanisms to
utilize unique carbon sources that donot exist in commensal microbiota
members?
The repression of virulence gene
expression by a member of the
microbiota when EHEC is in the
presence of mucus raises many
unanswered questions. Would an
individual with an unbalanced
microbiota scant in Bacteroidetes
be more susceptible or less
susceptible to EHEC disease? Do the
varying concentrations of mucus and
fucose present throughout the entire
gastrointestinal tract have a direct
influence upon the colonization site
of EHEC within the large intestine?
Will high fucose concentrations
encountered by shedding EHEC
cause the pathogen to conserve its
energy by repressing virulence gene
expression and result in a pathogen
that is more or less fit for
transmission? Future research will no
doubt shed light on these issues.References
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YAP—Tumor Suppressor and
Oncoprotein?The Hippo signaling pathway exerts a growth-suppressive effect by inhibitory
phosphorylation of the oncogenic transcription co-activator Yki/YAP. A recent
study paradoxically reports that genetic removal of YAP enhances intestinal
stem cell expansion and regeneration.Vivian S.W. Li1,2,* and Hans Clevers1
Recent studies have demonstrated
important roles of the Hippo signaling
pathway in organ-size control during
development and tissue regeneration
[1]. The highly conserved Hippo
pathway was first identified in
Drosophila: upstream signals (the
identities of which are still under
debate) activate a serine/threonine
kinase cascade involving the kinases
Hippo and Warts (Wts), which in
turn leads to inhibitory phosphorylation
of the downstream transcriptional
co-activator Yorkie (Yki). Suppressionof the Hippo pathway or
overexpression of Yki results in
massive tissue overgrowth in
Drosophila [2], implying an oncogenic
role for Yki. In vertebrates, the
corresponding components are
the kinases Mst and Lats, and the
related transcriptional co-activators
Yes-associated protein (YAP) and
WW-domain-containing transcription
regulator 1 (TAZ) [1]. Transgenic
expression of YAP in the liver induces
uniform expansion of liver mass,
whereas prolonged expression of
YAP results in tumorigenesis [3].
These combined data demonstratethat the Hippo pathway is
a growth-suppressive pathway in
both flies and mammals, and that
the downstream effector Yki/YAP
is a highly potent oncogene.
Several recent studies have
addressed roles of the Hippo signaling
pathway in self-renewal and repair
of the intestinal epithelium. YAP
protein is expressed at the bottom of
crypts — the stem cell compartments
of the intestinal epithelium [4]. Genetic
inhibition of Hippo signaling results in
hyperplasia of the gut epithelium in
both Drosophila and mouse [5–7].
Consistently, activation of YAP in the
intestine results in expansion of
undifferentiated progenitor cells [4].
On the other hand, YAP appears to
be dispensable in normal intestinal
homeostasis since loss of intestinal
YAP leads to no visible defects [6]. To
study thepotential regulatory role of the
Hippo signaling pathway in intestinal
regeneration, Cai et al. [6] performed
a mouse study in the dextran sodium
sulfate (DSS)-colitismodel. YAPprotein
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Figure 1. Model of Wnt activation in wild-type and YAP-deficient intestine upon R-spondin
stimulation.
YAP deletion increases the number of Paneth cells after R-spondin induction, resulting in
massive amplification of the Wnt signal.
Dispatch
R111DSS-induced damage in regenerating
colonic crypts. When YAP was deleted,
the repair of DSS-induced intestinal
damage was severely impaired. All
of these data are consistent with
a model in which YAP serves as
a growth-promoting protein in the
process of intestinal regeneration.
A new study, published recently in
Nature [8], has now revealed an
unexpected role of YAP in intestinal
regeneration. Barry et al. [8]
re-assessed the function of YAP in
the mouse intestine. In contrast to
the previously reported expansion
of undifferentiated crypt progenitors
upon ubiquitous expression of YAP,
coincident with the nuclear
accumulation of the Wnt effector
b-catenin [4], Barry et al. [8] noted
that the Wnt signaling pathway was
inhibited and that intestinal stem
cell markers were reduced upon
overexpression of YAP protein
specifically in the intestine. As a
consequence, proliferative crypts
were lost.
The major discrepancy between
the two studies could possibly be
explained by data collection at different
time points. Doxycycline-induced YAP
expression in the Cai et al. study [6] was
maintained for up to 4.5 days and then
followed by doxycycline withdrawal to
analyze reversibility of the phenotype.
In the latter study by Barry et al. [8], the
degenerative crypt phenotype was
first observed at day 7 and was
accompanied by complete loss of
Paneth cells, which are intermingled
with stem cells at crypt bottoms. The
data suggest that YAP overexpression
inhibits the intestinal differentiation
program, which eventually causes
the Paneth cell loss. Of note, Paneth
cells are a crucial component of
the intestinal stem-cell niche [9].
Thus, YAP overexpression in the
intestine temporarily suppresses
differentiation in agreement with its
‘generic’ growth-promoting effect.
Prolonged expression of YAP will
eventually lead to loss of the niche
and — paradoxically — thus cause
progressive crypt degeneration.
Another set of surprising data from
the study by Barry et al. [8] implies
that YAP deletion can result in
opposite phenotypes in different
tissue-regenerative models. Barry et al.
[8] confirmed the previous finding that
YAP-deficient mice show an impaired
regenerative response after
DSS-induced tissue damage [6].Upon whole-body irradiation,
however, YAP-deficient mice
demonstrated crypt hyperplasia and
overgrowth in both small intestine
and colon [8]. The authors confirmed
the growth-suppressive function of
YAP by stimulation with the Wnt
agonist R-spondin1 (Rspo1) [10,11],
a potent growth factor for intestinal
crypts [12]. Loss of YAP increased
Wnt/Rspo1 hypersensitivity and
induced massive hyperplasia, which
was accompanied by upregulation of
Wnt targets and intestinal stem cell
markers [8]. Together, the data suggest
opposite roles for YAP: in one role,
YAP serves as an oncoprotein,
promoting growth upon DSS-induced
intestinal damage; and in the other role,
YAP is a growth-repressive protein that
restricts Wnt/Rspo1-induced intestinal
stem-cell expansion and regeneration
after irradiation-induced injury.
To better understand the distinct
roles of YAP in tissue regeneration, it is
important to distinguish themechanistic differences between
DSS- and irradiation-induced injury
models. Oral administration of DSS
disrupts mucin production by the
intestinal mucosa and induces an
inflammatory response, resulting in
colitis-like lesions. It has been reported
that DSS-induced intestinal epithelial
regeneration requires activation of the
Notch signaling pathway [13].
Treatment with DSS upregulates
expression of the Notch target gene
Hes1, whereas inhibition of Notch
activation using a gamma-secretase
inhibitor impairs DSS-induced
intestinal regeneration [13].
Interestingly, YAP overexpression has
been shown to induce the expansion of
Hes1-expressing crypt progenitor
cells, which in turn can be suppressed
by gamma-secretase inhibitors [4].
Consistently, knockdown of YAP
strongly decreases the abundance of
the Notch intracellular domain and of
Hes1 expression [7]. Taken together,
DSS treatment may activate Notch
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loss of YAP would thus impair
DSS-induced intestinal regeneration by
inactivating the Notch pathway. The
second injury model involves
whole-body irradiation. Proliferative
cells, such as crypt progenitors, are
exquisitely sensitive to irradiation. In
contrast to the DSS-induced
regeneration, Barry et al. [8] observed
upregulation of Wnt targets and
increased numbers of Paneth cells in
the YAP-deficient intestine after
irradiation. The authors suggest that
loss of YAP increases Wnt
hypersensitivity, which is confirmed by
the Rspo1 experiments. It is interesting
to note that the number of Paneth cells
is strikingly increased in the YAP
knockout mice in both irradiated and
Rspo1-stimulated conditions [8].
Paneth cells (as the essential intestinal
stem-cell niche cells) constitute amajor
source of Wnt [9]. The unexpected
phenotype observed in the irradiation
model could therefore be explained
by the fact that YAP deletion
increases the number of Paneth
cells upon (irradiation-induced or
Rspo1-stimulated) intestinal
regeneration (Figure 1). Further study
of the role of YAP in driving Paneth
cell differentiation may provide deeper
insights into the Hippo pathway and
tissue regeneration.
The Hippo signaling pathway is one
of several pathways that play crucial
roles in regulating the tissue
regeneration. The current dogmastates
that the Hippo pathway is a growth/
tumor-suppressive pathway, with its
downstream effector Yki/YAP acting as
a growth promoter/oncoprotein. The
findings of Barry et al. [8] regarding
YAP’s functions in the intestine
provide a layer of complexity to this
simple view of YAP. In fact, both
upregulation and downregulation of
YAP expression have been reported in
colorectal cancer patients [8,14]. For
a better understanding of the role of
YAP in colon cancer, it will be crucial to
unravel the (likely opposing) direct
and indirect effects of YAP on crypt
stem cells and their niches. Crosstalk of
the Hippo pathway with other signaling
pathways in homeostatic control of
crypts has been proposed. For
example, TAZ and YAP have been
reported tosuppress theWnt/b-catenin
pathway through direct binding to
Dishevelled [8,15] or b-catenin [16].
Further, Mst1/2 and YAP may regulate
the Notch pathway through controllingexpression of the Notch intracellular
domain andHes1 (see also above) [4,7].
Finally, YAP may activate the
phosphatidylinositol 3-kinase and
mTOR signaling pathways through
suppression of the PTEN phosphatase
[17]. However this story may unravel,
the Hippo pathway is taking center
stage as a key regulator of organ-size
control, tissue regeneration and
tumorigenesis.
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in Our Family TreeTwo new fossil jawbones from Kenya are claimed to confirm a diversity of early
Homo species. However, archaic species concepts and an inadequate fossil
record continue to obscure the origins of our genus.Tim White
Human bones are common in
cemeteries, but remains of our moreancient ancestors and relatives are
fewer, further between and notoriously
difficult to recover. This is particularly
true for fossils that are millions of years
